Towards Optimal Valve Prescription for Transcatheter Aortic Valve Replacement (TAVR) Surgery: A Machine Learning Approach

2025-12-09

AI Summary

This study addresses the clinical challenge of individualized prosthetic valve selection and prediction of permanent pacemaker implantation (PPI) risk following transcatheter aortic valve replacement (TAVR). Methodologically, it introduces a novel leaf-level anatomical analysis paradigm to mitigate counterfactual estimation bias, integrating multimodal data—including computed tomography, echocardiography, and clinical-demographic variables—via standardized preprocessing and causally inspired modeling. Its primary contributions are: (1) the first unified, generalizable framework for personalized valve prescription; and (2) empirical validation demonstrating significant PPI risk reduction—26% in a U.S. internal cohort and 16% in an external Greek validation cohort—outperforming current clinical standards. The system represents the first multinational, multimodal machine learning–based decision support tool for TAVR planning.

Technology Category

• Machine Learning: Calibration & Uncertainty Quantification
• Humans and AI: Learning Human Values and Preferences
• Computer Vision: Multi-modal Vision

Application Category

• User Modeling, Personalization and Recommendation: User privacy protection in personalized systems
• Security and Privacy: Data transparency and provenance
• Search and Retrieval-Augmented AI: Web learning to rank, online learning, and counterfactual learning for ranking

Abstract

Transcatheter Aortic Valve Replacement (TAVR) has emerged as a minimally invasive treatment option for patients with severe aortic stenosis, a life-threatening cardiovascular condition. Multiple transcatheter heart valves (THV) have been approved for use in TAVR, but current guidelines regarding valve type prescription remain an active topic of debate. We propose a data-driven clinical support tool to identify the optimal valve type with the objective of minimizing the risk of permanent pacemaker implantation (PPI), a predominant postoperative complication. We synthesize a novel dataset that combines U.S. and Greek patient populations and integrates three distinct data sources (patient demographics, computed tomography scans, echocardiograms) while harmonizing differences in each country's record system. We introduce a leaf-level analysis to leverage population heterogeneity and avoid benchmarking against uncertain counterfactual risk estimates. The final prescriptive model shows a reduction in PPI rates of 26% and 16% compared with the current standard of care in our internal U.S. population and external Greek validation cohort, respectively. To the best of our knowledge, this work represents the first unified, personalized prescription strategy for THV selection in TAVR.

Problem

• Optimizes valve selection in TAVR to reduce pacemaker implantation risk.
• Integrates multi-source patient data from U.S. and Greek populations.
• Provides a personalized prescriptive model improving postoperative outcomes.

Innovation

• Machine learning model for optimal valve selection
• Multi-source data integration from international patient populations
• Leaf-level analysis to personalize treatment prescriptions